CD40 Ligand Market, Global Outlook and Forecast 2022-2028

March 2022 | 72 pages | ID: CBE23E379DC9EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of CD40 Ligand in global, including the following market information:

Global CD40 Ligand Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global CD40 Ligand Market Sales, 2017-2022, 2023-2028, (K Pcs)

Global top five CD40 Ligand companies in 2021 (%)

The global CD40 Ligand market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

ISF-35 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of CD40 Ligand include Biogen, Inc., Bristol-Myers Squibb Company, eTheRNA Immunotherapies NV, ImmuNext, Inc., Juno Therapeutics Inc., MedImmune, LLC, Targovax AS and XL-protein GmbH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CD40 Ligand manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global CD40 Ligand Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global CD40 Ligand Market Segment Percentages, by Type, 2021 (%)

• ISF-35
• LOAd-700
• MEDI-4920
• MegaCD40L
• Others

Global CD40 Ligand Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global CD40 Ligand Market Segment Percentages, by Application, 2021 (%)

• Hepatitis B
• Bladder Cancer
• Liver Cancer
• Ovarian Cancer
• Others

Global CD40 Ligand Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global CD40 Ligand Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies CD40 Ligand revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies CD40 Ligand revenues share in global market, 2021 (%)

Key companies CD40 Ligand sales in global market, 2017-2022 (Estimated), (K Pcs)

Key companies CD40 Ligand sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Biogen, Inc.
• Bristol-Myers Squibb Company
• eTheRNA Immunotherapies NV
• ImmuNext, Inc.
• Juno Therapeutics Inc.
• MedImmune, LLC
• Targovax AS
• XL-protein GmbH

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 CD40 Ligand Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global CD40 Ligand Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CD40 LIGAND OVERALL MARKET SIZE

2.1 Global CD40 Ligand Market Size: 2021 VS 2028
2.2 Global CD40 Ligand Revenue, Prospects & Forecasts: 2017-2028
2.3 Global CD40 Ligand Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top CD40 Ligand Players in Global Market
3.2 Top Global CD40 Ligand Companies Ranked by Revenue
3.3 Global CD40 Ligand Revenue by Companies
3.4 Global CD40 Ligand Sales by Companies
3.5 Global CD40 Ligand Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 CD40 Ligand Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers CD40 Ligand Product Type
3.8 Tier 1, Tier 2 and Tier 3 CD40 Ligand Players in Global Market
  3.8.1 List of Global Tier 1 CD40 Ligand Companies
  3.8.2 List of Global Tier 2 and Tier 3 CD40 Ligand Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global CD40 Ligand Market Size Markets, 2021 & 2028
  4.1.2 ISF-35
  4.1.3 LOAd-700
  4.1.4 MEDI-4920
  4.1.5 MegaCD40L
  4.1.6 Others
4.2 By Type - Global CD40 Ligand Revenue & Forecasts
  4.2.1 By Type - Global CD40 Ligand Revenue, 2017-2022
  4.2.2 By Type - Global CD40 Ligand Revenue, 2023-2028
  4.2.3 By Type - Global CD40 Ligand Revenue Market Share, 2017-2028
4.3 By Type - Global CD40 Ligand Sales & Forecasts
  4.3.1 By Type - Global CD40 Ligand Sales, 2017-2022
  4.3.2 By Type - Global CD40 Ligand Sales, 2023-2028
  4.3.3 By Type - Global CD40 Ligand Sales Market Share, 2017-2028
4.4 By Type - Global CD40 Ligand Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global CD40 Ligand Market Size, 2021 & 2028
  5.1.2 Hepatitis B
  5.1.3 Bladder Cancer
  5.1.4 Liver Cancer
  5.1.5 Ovarian Cancer
  5.1.6 Others
5.2 By Application - Global CD40 Ligand Revenue & Forecasts
  5.2.1 By Application - Global CD40 Ligand Revenue, 2017-2022
  5.2.2 By Application - Global CD40 Ligand Revenue, 2023-2028
  5.2.3 By Application - Global CD40 Ligand Revenue Market Share, 2017-2028
5.3 By Application - Global CD40 Ligand Sales & Forecasts
  5.3.1 By Application - Global CD40 Ligand Sales, 2017-2022
  5.3.2 By Application - Global CD40 Ligand Sales, 2023-2028
  5.3.3 By Application - Global CD40 Ligand Sales Market Share, 2017-2028
5.4 By Application - Global CD40 Ligand Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global CD40 Ligand Market Size, 2021 & 2028
6.2 By Region - Global CD40 Ligand Revenue & Forecasts
  6.2.1 By Region - Global CD40 Ligand Revenue, 2017-2022
  6.2.2 By Region - Global CD40 Ligand Revenue, 2023-2028
  6.2.3 By Region - Global CD40 Ligand Revenue Market Share, 2017-2028
6.3 By Region - Global CD40 Ligand Sales & Forecasts
  6.3.1 By Region - Global CD40 Ligand Sales, 2017-2022
  6.3.2 By Region - Global CD40 Ligand Sales, 2023-2028
  6.3.3 By Region - Global CD40 Ligand Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America CD40 Ligand Revenue, 2017-2028
  6.4.2 By Country - North America CD40 Ligand Sales, 2017-2028
  6.4.3 US CD40 Ligand Market Size, 2017-2028
  6.4.4 Canada CD40 Ligand Market Size, 2017-2028
  6.4.5 Mexico CD40 Ligand Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe CD40 Ligand Revenue, 2017-2028
  6.5.2 By Country - Europe CD40 Ligand Sales, 2017-2028
  6.5.3 Germany CD40 Ligand Market Size, 2017-2028
  6.5.4 France CD40 Ligand Market Size, 2017-2028
  6.5.5 U.K. CD40 Ligand Market Size, 2017-2028
  6.5.6 Italy CD40 Ligand Market Size, 2017-2028
  6.5.7 Russia CD40 Ligand Market Size, 2017-2028
  6.5.8 Nordic Countries CD40 Ligand Market Size, 2017-2028
  6.5.9 Benelux CD40 Ligand Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia CD40 Ligand Revenue, 2017-2028
  6.6.2 By Region - Asia CD40 Ligand Sales, 2017-2028
  6.6.3 China CD40 Ligand Market Size, 2017-2028
  6.6.4 Japan CD40 Ligand Market Size, 2017-2028
  6.6.5 South Korea CD40 Ligand Market Size, 2017-2028
  6.6.6 Southeast Asia CD40 Ligand Market Size, 2017-2028
  6.6.7 India CD40 Ligand Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America CD40 Ligand Revenue, 2017-2028
  6.7.2 By Country - South America CD40 Ligand Sales, 2017-2028
  6.7.3 Brazil CD40 Ligand Market Size, 2017-2028
  6.7.4 Argentina CD40 Ligand Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa CD40 Ligand Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa CD40 Ligand Sales, 2017-2028
  6.8.3 Turkey CD40 Ligand Market Size, 2017-2028
  6.8.4 Israel CD40 Ligand Market Size, 2017-2028
  6.8.5 Saudi Arabia CD40 Ligand Market Size, 2017-2028
  6.8.6 UAE CD40 Ligand Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Biogen, Inc.
  7.1.1 Biogen, Inc. Corporate Summary
  7.1.2 Biogen, Inc. Business Overview
  7.1.3 Biogen, Inc. CD40 Ligand Major Product Offerings
  7.1.4 Biogen, Inc. CD40 Ligand Sales and Revenue in Global (2017-2022)
  7.1.5 Biogen, Inc. Key News
7.2 Bristol-Myers Squibb Company
  7.2.1 Bristol-Myers Squibb Company Corporate Summary
  7.2.2 Bristol-Myers Squibb Company Business Overview
  7.2.3 Bristol-Myers Squibb Company CD40 Ligand Major Product Offerings
  7.2.4 Bristol-Myers Squibb Company CD40 Ligand Sales and Revenue in Global (2017-2022)
  7.2.5 Bristol-Myers Squibb Company Key News
7.3 eTheRNA Immunotherapies NV
  7.3.1 eTheRNA Immunotherapies NV Corporate Summary
  7.3.2 eTheRNA Immunotherapies NV Business Overview
  7.3.3 eTheRNA Immunotherapies NV CD40 Ligand Major Product Offerings
  7.3.4 eTheRNA Immunotherapies NV CD40 Ligand Sales and Revenue in Global (2017-2022)
  7.3.5 eTheRNA Immunotherapies NV Key News
7.4 ImmuNext, Inc.
  7.4.1 ImmuNext, Inc. Corporate Summary
  7.4.2 ImmuNext, Inc. Business Overview
  7.4.3 ImmuNext, Inc. CD40 Ligand Major Product Offerings
  7.4.4 ImmuNext, Inc. CD40 Ligand Sales and Revenue in Global (2017-2022)
  7.4.5 ImmuNext, Inc. Key News
7.5 Juno Therapeutics Inc.
  7.5.1 Juno Therapeutics Inc. Corporate Summary
  7.5.2 Juno Therapeutics Inc. Business Overview
  7.5.3 Juno Therapeutics Inc. CD40 Ligand Major Product Offerings
  7.5.4 Juno Therapeutics Inc. CD40 Ligand Sales and Revenue in Global (2017-2022)
  7.5.5 Juno Therapeutics Inc. Key News
7.6 MedImmune, LLC
  7.6.1 MedImmune, LLC Corporate Summary
  7.6.2 MedImmune, LLC Business Overview
  7.6.3 MedImmune, LLC CD40 Ligand Major Product Offerings
  7.6.4 MedImmune, LLC CD40 Ligand Sales and Revenue in Global (2017-2022)
  7.6.5 MedImmune, LLC Key News
7.7 Targovax AS
  7.7.1 Targovax AS Corporate Summary
  7.7.2 Targovax AS Business Overview
  7.7.3 Targovax AS CD40 Ligand Major Product Offerings
  7.7.4 Targovax AS CD40 Ligand Sales and Revenue in Global (2017-2022)
  7.7.5 Targovax AS Key News
7.8 XL-protein GmbH
  7.8.1 XL-protein GmbH Corporate Summary
  7.8.2 XL-protein GmbH Business Overview
  7.8.3 XL-protein GmbH CD40 Ligand Major Product Offerings
  7.8.4 XL-protein GmbH CD40 Ligand Sales and Revenue in Global (2017-2022)
  7.8.5 XL-protein GmbH Key News

8 GLOBAL CD40 LIGAND PRODUCTION CAPACITY, ANALYSIS

8.1 Global CD40 Ligand Production Capacity, 2017-2028
8.2 CD40 Ligand Production Capacity of Key Manufacturers in Global Market
8.3 Global CD40 Ligand Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 CD40 LIGAND SUPPLY CHAIN ANALYSIS

10.1 CD40 Ligand Industry Value Chain
10.2 CD40 Ligand Upstream Market
10.3 CD40 Ligand Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 CD40 Ligand Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of CD40 Ligand in Global Market
Table 2. Top CD40 Ligand Players in Global Market, Ranking by Revenue (2021)
Table 3. Global CD40 Ligand Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global CD40 Ligand Revenue Share by Companies, 2017-2022
Table 5. Global CD40 Ligand Sales by Companies, (K Pcs), 2017-2022
Table 6. Global CD40 Ligand Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers CD40 Ligand Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers CD40 Ligand Product Type
Table 9. List of Global Tier 1 CD40 Ligand Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CD40 Ligand Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global CD40 Ligand Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global CD40 Ligand Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global CD40 Ligand Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global CD40 Ligand Sales (K Pcs), 2017-2022
Table 15. By Type - Global CD40 Ligand Sales (K Pcs), 2023-2028
Table 16. By Application – Global CD40 Ligand Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global CD40 Ligand Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global CD40 Ligand Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global CD40 Ligand Sales (K Pcs), 2017-2022
Table 20. By Application - Global CD40 Ligand Sales (K Pcs), 2023-2028
Table 21. By Region – Global CD40 Ligand Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global CD40 Ligand Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global CD40 Ligand Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global CD40 Ligand Sales (K Pcs), 2017-2022
Table 25. By Region - Global CD40 Ligand Sales (K Pcs), 2023-2028
Table 26. By Country - North America CD40 Ligand Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America CD40 Ligand Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America CD40 Ligand Sales, (K Pcs), 2017-2022
Table 29. By Country - North America CD40 Ligand Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe CD40 Ligand Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe CD40 Ligand Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe CD40 Ligand Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe CD40 Ligand Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia CD40 Ligand Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia CD40 Ligand Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia CD40 Ligand Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia CD40 Ligand Sales, (K Pcs), 2023-2028
Table 38. By Country - South America CD40 Ligand Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America CD40 Ligand Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America CD40 Ligand Sales, (K Pcs), 2017-2022
Table 41. By Country - South America CD40 Ligand Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa CD40 Ligand Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa CD40 Ligand Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa CD40 Ligand Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa CD40 Ligand Sales, (K Pcs), 2023-2028
Table 46. Biogen, Inc. Corporate Summary
Table 47. Biogen, Inc. CD40 Ligand Product Offerings
Table 48. Biogen, Inc. CD40 Ligand Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Bristol-Myers Squibb Company Corporate Summary
Table 50. Bristol-Myers Squibb Company CD40 Ligand Product Offerings
Table 51. Bristol-Myers Squibb Company CD40 Ligand Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. eTheRNA Immunotherapies NV Corporate Summary
Table 53. eTheRNA Immunotherapies NV CD40 Ligand Product Offerings
Table 54. eTheRNA Immunotherapies NV CD40 Ligand Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. ImmuNext, Inc. Corporate Summary
Table 56. ImmuNext, Inc. CD40 Ligand Product Offerings
Table 57. ImmuNext, Inc. CD40 Ligand Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Juno Therapeutics Inc. Corporate Summary
Table 59. Juno Therapeutics Inc. CD40 Ligand Product Offerings
Table 60. Juno Therapeutics Inc. CD40 Ligand Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. MedImmune, LLC Corporate Summary
Table 62. MedImmune, LLC CD40 Ligand Product Offerings
Table 63. MedImmune, LLC CD40 Ligand Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Targovax AS Corporate Summary
Table 65. Targovax AS CD40 Ligand Product Offerings
Table 66. Targovax AS CD40 Ligand Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. XL-protein GmbH Corporate Summary
Table 68. XL-protein GmbH CD40 Ligand Product Offerings
Table 69. XL-protein GmbH CD40 Ligand Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. CD40 Ligand Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 71. Global CD40 Ligand Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global CD40 Ligand Production by Region, 2017-2022 (K Pcs)
Table 73. Global CD40 Ligand Production by Region, 2023-2028 (K Pcs)
Table 74. CD40 Ligand Market Opportunities & Trends in Global Market
Table 75. CD40 Ligand Market Drivers in Global Market
Table 76. CD40 Ligand Market Restraints in Global Market
Table 77. CD40 Ligand Raw Materials
Table 78. CD40 Ligand Raw Materials Suppliers in Global Market
Table 79. Typical CD40 Ligand Downstream
Table 80. CD40 Ligand Downstream Clients in Global Market
Table 81. CD40 Ligand Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. CD40 Ligand Segment by Type
Figure 2. CD40 Ligand Segment by Application
Figure 3. Global CD40 Ligand Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global CD40 Ligand Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global CD40 Ligand Revenue, 2017-2028 (US$, Mn)
Figure 7. CD40 Ligand Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by CD40 Ligand Revenue in 2021
Figure 9. By Type - Global CD40 Ligand Sales Market Share, 2017-2028
Figure 10. By Type - Global CD40 Ligand Revenue Market Share, 2017-2028
Figure 11. By Type - Global CD40 Ligand Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global CD40 Ligand Sales Market Share, 2017-2028
Figure 13. By Application - Global CD40 Ligand Revenue Market Share, 2017-2028
Figure 14. By Application - Global CD40 Ligand Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global CD40 Ligand Sales Market Share, 2017-2028
Figure 16. By Region - Global CD40 Ligand Revenue Market Share, 2017-2028
Figure 17. By Country - North America CD40 Ligand Revenue Market Share, 2017-2028
Figure 18. By Country - North America CD40 Ligand Sales Market Share, 2017-2028
Figure 19. US CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 20. Canada CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe CD40 Ligand Revenue Market Share, 2017-2028
Figure 23. By Country - Europe CD40 Ligand Sales Market Share, 2017-2028
Figure 24. Germany CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 25. France CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 27. Italy CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 28. Russia CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia CD40 Ligand Revenue Market Share, 2017-2028
Figure 32. By Region - Asia CD40 Ligand Sales Market Share, 2017-2028
Figure 33. China CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 34. Japan CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 37. India CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America CD40 Ligand Revenue Market Share, 2017-2028
Figure 39. By Country - South America CD40 Ligand Sales Market Share, 2017-2028
Figure 40. Brazil CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa CD40 Ligand Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa CD40 Ligand Sales Market Share, 2017-2028
Figure 44. Turkey CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 45. Israel CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 47. UAE CD40 Ligand Revenue, (US$, Mn), 2017-2028
Figure 48. Global CD40 Ligand Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production CD40 Ligand by Region, 2021 VS 2028
Figure 50. CD40 Ligand Industry Value Chain
Figure 51. Marketing Channels